longtext: 4EZI-pdb

content
HEADER    UNKNOWN FUNCTION                        02-MAY-12   4EZI
TITLE     CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN (LPG1103) FROM LEGIONELLA
TITLE    2 PNEUMOPHILA SUBSP. PNEUMOPHILA STR. PHILADELPHIA 1 AT 1.15 A
TITLE    3 RESOLUTION
COMPND    MOL_ID: 1;
COMPND   2 MOLECULE: UNCHARACTERIZED PROTEIN;
COMPND   3 CHAIN: A;
COMPND   4 ENGINEERED: YES
SOURCE    MOL_ID: 1;
SOURCE   2 ORGANISM_SCIENTIFIC: LEGIONELLA PNEUMOPHILA SUBSP. PNEUMOPHILA STR.
SOURCE   3 PHILADELPHIA 1;
SOURCE   4 ORGANISM_TAXID: 272624;
SOURCE   5 STRAIN: PHILADELPHIA 1 / ATCC 33152 / DSM 7513;
SOURCE   6 GENE: LPG1103;
SOURCE   7 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE   8 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE   9 EXPRESSION_SYSTEM_STRAIN: PB1;
SOURCE  10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE  11 EXPRESSION_SYSTEM_PLASMID: SPEEDET
KEYWDS    ALPHA-BETA HYDROLASES FOLD, STRUCTURAL GENOMICS, JOINT CENTER FOR
KEYWDS   2 STRUCTURAL GENOMICS, JCSG, PROTEIN STRUCTURE INITIATIVE, PSI-
KEYWDS   3 BIOLOGY, UNKNOWN FUNCTION
EXPDTA    X-RAY DIFFRACTION
AUTHOR    JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG)
REVDAT   1   27-JUN-12 4EZI    0
JRNL        AUTH   JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG)
JRNL        TITL   CRYSTAL STRUCTURE OF A HYPOTHETICAL PROTEIN (LPG1103) FROM
JRNL        TITL 2 LEGIONELLA PNEUMOPHILA SUBSP. PNEUMOPHILA STR. PHILADELPHIA
JRNL        TITL 3 1 AT 1.15 A RESOLUTION
JRNL        REF    TO BE PUBLISHED
JRNL        REFN
REMARK   2
REMARK   2 RESOLUTION.    1.15 ANGSTROMS.
REMARK   3
REMARK   3 REFINEMENT.
REMARK   3   PROGRAM     : REFMAC 5.5.0110
REMARK   3   AUTHORS     : MURSHUDOV,VAGIN,DODSON
REMARK   3
REMARK   3    REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES
REMARK   3
REMARK   3  DATA USED IN REFINEMENT.
REMARK   3   RESOLUTION RANGE HIGH (ANGSTROMS) : 1.15
REMARK   3   RESOLUTION RANGE LOW  (ANGSTROMS) : 28.64
REMARK   3   DATA CUTOFF            (SIGMA(F)) : 0.000
REMARK   3   COMPLETENESS FOR RANGE        (%) : 99.8
REMARK   3   NUMBER OF REFLECTIONS             : 131826
REMARK   3
REMARK   3  FIT TO DATA USED IN REFINEMENT.
REMARK   3   CROSS-VALIDATION METHOD          : THROUGHOUT
REMARK   3   FREE R VALUE TEST SET SELECTION  : RANDOM
REMARK   3   R VALUE     (WORKING + TEST SET) : 0.137
REMARK   3   R VALUE            (WORKING SET) : 0.135
REMARK   3   FREE R VALUE                     : 0.157
REMARK   3   FREE R VALUE TEST SET SIZE   (%) : 5.000
REMARK   3   FREE R VALUE TEST SET COUNT      : 6631
REMARK   3
REMARK   3  FIT IN THE HIGHEST RESOLUTION BIN.
REMARK   3   TOTAL NUMBER OF BINS USED           : 20
REMARK   3   BIN RESOLUTION RANGE HIGH       (A) : 1.15
REMARK   3   BIN RESOLUTION RANGE LOW        (A) : 1.18
REMARK   3   REFLECTION IN BIN     (WORKING SET) : 9084
REMARK   3   BIN COMPLETENESS (WORKING+TEST) (%) : 99.22
REMARK   3   BIN R VALUE           (WORKING SET) : 0.2690
REMARK   3   BIN FREE R VALUE SET COUNT          : 545
REMARK   3   BIN FREE R VALUE                    : 0.2960
REMARK   3
REMARK   3  NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK   3   PROTEIN ATOMS            : 2962
REMARK   3   NUCLEIC ACID ATOMS       : 0
REMARK   3   HETEROGEN ATOMS          : 8
REMARK   3   SOLVENT ATOMS            : 536
REMARK   3
REMARK   3  B VALUES.
REMARK   3   FROM WILSON PLOT           (A**2) : 9.25
REMARK   3   MEAN B VALUE      (OVERALL, A**2) : 13.89
REMARK   3   OVERALL ANISOTROPIC B VALUE.
REMARK   3    B11 (A**2) : 0.20000
REMARK   3    B22 (A**2) : -0.11000
REMARK   3    B33 (A**2) : -0.09000
REMARK   3    B12 (A**2) : 0.00000
REMARK   3    B13 (A**2) : 0.00000
REMARK   3    B23 (A**2) : 0.00000
REMARK   3
REMARK   3  ESTIMATED OVERALL COORDINATE ERROR.
REMARK   3   ESU BASED ON R VALUE                            (A): 0.032
REMARK   3   ESU BASED ON FREE R VALUE                       (A): 0.032
REMARK   3   ESU BASED ON MAXIMUM LIKELIHOOD                 (A): 0.020
REMARK   3   ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 1.002
REMARK   3
REMARK   3 CORRELATION COEFFICIENTS.
REMARK   3   CORRELATION COEFFICIENT FO-FC      : 0.980
REMARK   3   CORRELATION COEFFICIENT FO-FC FREE : 0.975
REMARK   3
REMARK   3  RMS DEVIATIONS FROM IDEAL VALUES        COUNT    RMS    WEIGHT
REMARK   3   BOND LENGTHS REFINED ATOMS        (A):  3292 ; 0.011 ; 0.022
REMARK   3   BOND LENGTHS OTHERS               (A):  2214 ; 0.001 ; 0.020
REMARK   3   BOND ANGLES REFINED ATOMS   (DEGREES):  4507 ; 1.428 ; 1.962
REMARK   3   BOND ANGLES OTHERS          (DEGREES):  5439 ; 0.951 ; 3.000
REMARK   3   TORSION ANGLES, PERIOD 1    (DEGREES):   416 ; 5.845 ; 5.000
REMARK   3   TORSION ANGLES, PERIOD 2    (DEGREES):   160 ;37.149 ;24.563
REMARK   3   TORSION ANGLES, PERIOD 3    (DEGREES):   541 ;11.786 ;15.000
REMARK   3   TORSION ANGLES, PERIOD 4    (DEGREES):    11 ;21.892 ;15.000
REMARK   3   CHIRAL-CENTER RESTRAINTS       (A**3):   485 ; 0.092 ; 0.200
REMARK   3   GENERAL PLANES REFINED ATOMS      (A):  3696 ; 0.009 ; 0.021
REMARK   3   GENERAL PLANES OTHERS             (A):   680 ; 0.002 ; 0.020
REMARK   3   NON-BONDED CONTACTS REFINED ATOMS (A):  NULL ;  NULL ;  NULL
REMARK   3   NON-BONDED CONTACTS OTHERS        (A):  NULL ;  NULL ;  NULL
REMARK   3   NON-BONDED TORSION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL
REMARK   3   NON-BONDED TORSION OTHERS         (A):  NULL ;  NULL ;  NULL
REMARK   3   H-BOND (X...Y) REFINED ATOMS      (A):  NULL ;  NULL ;  NULL
REMARK   3   H-BOND (X...Y) OTHERS             (A):  NULL ;  NULL ;  NULL
REMARK   3   POTENTIAL METAL-ION REFINED ATOMS (A):  NULL ;  NULL ;  NULL
REMARK   3   POTENTIAL METAL-ION OTHERS        (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY VDW REFINED ATOMS        (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY VDW OTHERS               (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY H-BOND REFINED ATOMS     (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY H-BOND OTHERS            (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY METAL-ION REFINED ATOMS  (A):  NULL ;  NULL ;  NULL
REMARK   3   SYMMETRY METAL-ION OTHERS         (A):  NULL ;  NULL ;  NULL
REMARK   3
REMARK   3  ISOTROPIC THERMAL FACTOR RESTRAINTS.     COUNT   RMS    WEIGHT
REMARK   3   MAIN-CHAIN BOND REFINED ATOMS  (A**2):  1972 ; 1.898 ; 3.000
REMARK   3   MAIN-CHAIN BOND OTHER ATOMS    (A**2):   778 ; 1.390 ; 3.000
REMARK   3   MAIN-CHAIN ANGLE REFINED ATOMS (A**2):  3221 ; 2.691 ; 5.000
REMARK   3   SIDE-CHAIN BOND REFINED ATOMS  (A**2):  1320 ; 3.642 ; 8.000
REMARK   3   SIDE-CHAIN ANGLE REFINED ATOMS (A**2):  1269 ; 5.188 ;11.000
REMARK   3
REMARK   3 ANISOTROPIC THERMAL FACTOR RESTRAINTS.    COUNT   RMS   WEIGHT
REMARK   3   RIGID-BOND RESTRAINTS          (A**2):  5506 ; 1.464 ; 3.000
REMARK   3   SPHERICITY; FREE ATOMS         (A**2):   539 ; 6.748 ; 3.000
REMARK   3   SPHERICITY; BONDED ATOMS       (A**2):  5395 ; 3.568 ; 3.000
REMARK   3
REMARK   3  NCS RESTRAINTS STATISTICS
REMARK   3   NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK   3
REMARK   3  TLS DETAILS
REMARK   3   NUMBER OF TLS GROUPS  : NULL
REMARK   3
REMARK   3  BULK SOLVENT MODELLING.
REMARK   3   METHOD USED : MASK
REMARK   3   PARAMETERS FOR MASK CALCULATION
REMARK   3   VDW PROBE RADIUS   : 1.40
REMARK   3   ION PROBE RADIUS   : 0.80
REMARK   3   SHRINKAGE RADIUS   : 0.80
REMARK   3
REMARK   3  OTHER REFINEMENT REMARKS: 1. HYDROGENS HAVE BEEN ADDED IN THE
REMARK   3  RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR
REMARK   3  SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE
REMARK   3  OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75
REMARK   3  FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET
REMARK   3  INCORPORATION. 3. POLYETHYLENE GLYCOL (PEG) AND CHLORIDE (CL)
REMARK   3  FROM THE CRYSTALLIZATION SOLUTION HAVE BEEN MODELED INTO THE
REMARK   3  STRUCTURE.
REMARK   4
REMARK   4 4EZI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-MAY-12.
REMARK 100 THE RCSB ID CODE IS RCSB072264.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200  EXPERIMENT TYPE                : X-RAY DIFFRACTION
REMARK 200  DATE OF DATA COLLECTION        : 16-MAR-12
REMARK 200  TEMPERATURE           (KELVIN) : 100
REMARK 200  PH                             : 8.5
REMARK 200  NUMBER OF CRYSTALS USED        : 1
REMARK 200
REMARK 200  SYNCHROTRON              (Y/N) : Y
REMARK 200  RADIATION SOURCE               : SSRL
REMARK 200  BEAMLINE                       : BL14-1
REMARK 200  X-RAY GENERATOR MODEL          : NULL
REMARK 200  MONOCHROMATIC OR LAUE    (M/L) : M
REMARK 200  WAVELENGTH OR RANGE        (A) : 0.97916
REMARK 200  MONOCHROMATOR                  : DOUBLE CRYSTAL SI(111)
REMARK 200  OPTICS                         : VERTICAL FOCUSING MIRROR; DOUBLE
REMARK 200                                   CRYSTAL SI(111) MONOCHROMATOR
REMARK 200
REMARK 200  DETECTOR TYPE                  : CCD
REMARK 200  DETECTOR MANUFACTURER          : MARMOSAIC 325 MM CCD
REMARK 200  INTENSITY-INTEGRATION SOFTWARE : MOSFLM
REMARK 200  DATA SCALING SOFTWARE          : SCALA
REMARK 200
REMARK 200  NUMBER OF UNIQUE REFLECTIONS   : 131916
REMARK 200  RESOLUTION RANGE HIGH      (A) : 1.150
REMARK 200  RESOLUTION RANGE LOW       (A) : 28.637
REMARK 200  REJECTION CRITERIA  (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200  COMPLETENESS FOR RANGE     (%) : 99.9
REMARK 200  DATA REDUNDANCY                : 5.200
REMARK 200  R MERGE                    (I) : NULL
REMARK 200  R SYM                      (I) : 0.10600
REMARK 200   FOR THE DATA SET  : 7.1000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.15
REMARK 200  HIGHEST RESOLUTION SHELL, RANGE LOW  (A) : 1.18
REMARK 200  COMPLETENESS FOR SHELL     (%) : 99.3
REMARK 200  DATA REDUNDANCY IN SHELL       : 4.70
REMARK 200  R MERGE FOR SHELL          (I) : 0.78700
REMARK 200  R SYM FOR SHELL            (I) : 0.78700
REMARK 200   FOR SHELL         : 1.000
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD
REMARK 200 SOFTWARE USED: SHELXD,SHARP
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS   (%): 42.47
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.20M SODIUM ACETATE, 30.00%
REMARK 280  POLYETHYLENE GLYCOL 4000, 0.1M TRIS HYDROCHLORIDE PH 8.5,
REMARK 280  NANODROP, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21
REMARK 290
REMARK 290      SYMOP   SYMMETRY
REMARK 290     NNNMMM   OPERATOR
REMARK 290       1555   X,Y,Z
REMARK 290       2555   -X+1/2,-Y,Z+1/2
REMARK 290       3555   -X,Y+1/2,-Z+1/2
REMARK 290       4555   X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290     WHERE NNN -> OPERATOR NUMBER
REMARK 290           MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290   SMTRY1   1  1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   1  0.000000  1.000000  0.000000        0.00000
REMARK 290   SMTRY3   1  0.000000  0.000000  1.000000        0.00000
REMARK 290   SMTRY1   2 -1.000000  0.000000  0.000000       25.43750
REMARK 290   SMTRY2   2  0.000000 -1.000000  0.000000        0.00000
REMARK 290   SMTRY3   2  0.000000  0.000000  1.000000       57.27450
REMARK 290   SMTRY1   3 -1.000000  0.000000  0.000000        0.00000
REMARK 290   SMTRY2   3  0.000000  1.000000  0.000000       31.74400
REMARK 290   SMTRY3   3  0.000000  0.000000 -1.000000       57.27450
REMARK 290   SMTRY1   4  1.000000  0.000000  0.000000       25.43750
REMARK 290   SMTRY2   4  0.000000 -1.000000  0.000000       31.74400
REMARK 290   SMTRY3   4  0.000000  0.000000 -1.000000        0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW.  BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350   BIOMT1   1  1.000000  0.000000  0.000000        0.00000
REMARK 350   BIOMT2   1  0.000000  1.000000  0.000000        0.00000
REMARK 350   BIOMT3   1  0.000000  0.000000  1.000000        0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465   M RES C SSSEQI
REMARK 465     GLY A     0
REMARK 465     ALA A    28
REMARK 465     LEU A    29
REMARK 465     GLU A    30
REMARK 465     HIS A    31
REMARK 465     LYS A   403
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470   M RES CSSEQI  ATOMS
REMARK 470     GLU A  32    CG   CD   OE1  OE2
REMARK 470     LYS A  53    CE   NZ
REMARK 470     MSE A 401    CG  SE    CE
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500  M RES CSSEQI        PSI       PHI
REMARK 500    ASN A 120       62.78     37.89
REMARK 500    SER A 134      -64.05    -90.37
REMARK 500    TYR A 144      157.60     86.64
REMARK 500    SER A 195     -123.44     63.74
REMARK 500    PHE A 365       58.66    -91.35
REMARK 500    ALA A 374      -17.32   -140.12
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG A 501
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 502
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: JCSG-418740   RELATED DB: TARGETTRACK
REMARK 999
REMARK 999 SEQUENCE
REMARK 999 THE CONSTRUCT (RESIDUES 28-403) WAS EXPRESSED WITH A PURIFICATION
REMARK 999 TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE
REMARK 999 LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE.
DBREF  4EZI A   28   403  UNP    Q5ZWI2   Q5ZWI2_LEGPH    28    403
SEQADV 4EZI GLY A    0  UNP  Q5ZWI2              LEADER SEQUENCE
SEQRES   1 A  377  GLY ALA LEU GLU HIS GLU LYS LEU VAL ASN TYR ILE ALA
SEQRES   2 A  377  LEU GLY GLU PHE SER ARG GLU THR ALA GLU ILE ALA LEU
SEQRES   3 A  377  LYS LYS MSE PRO PRO LEU ASP THR LEU THR VAL HIS TYR
SEQRES   4 A  377  ASP LEU GLN LEU TYR LYS ILE ASN TYR LYS THR GLN SER
SEQRES   5 A  377  PRO ASP GLY ASN LEU THR ILE ALA SER GLY LEU VAL ALA
SEQRES   6 A  377  MSE PRO ILE HIS PRO VAL GLY GLN VAL GLY ILE ILE SER
SEQRES   7 A  377  TYR GLN HIS GLY THR ARG PHE GLU ARG ASN ASP VAL PRO
SEQRES   8 A  377  SER ARG ASN ASN GLU LYS ASN TYR ILE TYR LEU ALA ALA
SEQRES   9 A  377  TYR GLY ASN SER ALA GLY TYR MSE THR VAL MSE PRO ASP
SEQRES  10 A  377  TYR LEU GLY LEU GLY ASP ASN GLU LEU THR LEU HIS PRO
SEQRES  11 A  377  TYR VAL GLN ALA GLU THR LEU ALA SER SER SER ILE ASP
SEQRES  12 A  377  MSE LEU PHE ALA ALA LYS GLU LEU ALA ASN ARG LEU HIS
SEQRES  13 A  377  TYR PRO ILE SER ASP LYS LEU TYR LEU ALA GLY TYR SER
SEQRES  14 A  377  GLU GLY GLY PHE SER THR ILE VAL MSE PHE GLU MSE LEU
SEQRES  15 A  377  ALA LYS GLU TYR PRO ASP LEU PRO VAL SER ALA VAL ALA
SEQRES  16 A  377  PRO GLY SER ALA PRO TYR GLY TRP GLU GLU THR MSE HIS
SEQRES  17 A  377  PHE VAL MSE LEU GLU PRO GLY PRO ARG ALA THR ALA TYR
SEQRES  18 A  377  LEU ALA TYR PHE PHE TYR SER LEU GLN THR TYR LYS SER
SEQRES  19 A  377  TYR TRP SER GLY PHE ASP GLU ILE PHE ALA PRO PRO TYR
SEQRES  20 A  377  ASN THR LEU ILE PRO GLU LEU MSE ASP GLY TYR HIS ALA
SEQRES  21 A  377  VAL ASP GLU ILE LEU GLN ALA LEU PRO GLN ASP PRO LEU
SEQRES  22 A  377  LEU ILE PHE GLN PRO LYS PHE SER ASN GLY ILE ILE SER
SEQRES  23 A  377  LYS THR ASP ARG ASN THR GLU ILE LEU LYS ILE ASN PHE
SEQRES  24 A  377  ASN HIS TYR ASP PHE LYS PRO THR ALA PRO LEU LEU LEU
SEQRES  25 A  377  VAL GLY THR LYS GLY ASP ARG ASP VAL PRO TYR ALA GLY
SEQRES  26 A  377  ALA GLU MSE ALA TYR HIS SER PHE ARG LYS TYR SER ASP
SEQRES  27 A  377  PHE VAL TRP ILE LYS SER VAL SER ASP ALA LEU ASP HIS
SEQRES  28 A  377  VAL GLN ALA HIS PRO PHE VAL LEU LYS GLU GLN VAL ASP
SEQRES  29 A  377  PHE PHE LYS GLN PHE GLU ARG GLN GLU ALA MSE ASN LYS
MODRES 4EZI MSE A   55  MET  SELENOMETHIONINE
MODRES 4EZI MSE A   92  MET  SELENOMETHIONINE
MODRES 4EZI MSE A  138  MET  SELENOMETHIONINE
MODRES 4EZI MSE A  141  MET  SELENOMETHIONINE
MODRES 4EZI MSE A  170  MET  SELENOMETHIONINE
MODRES 4EZI MSE A  204  MET  SELENOMETHIONINE
MODRES 4EZI MSE A  207  MET  SELENOMETHIONINE
MODRES 4EZI MSE A  233  MET  SELENOMETHIONINE
MODRES 4EZI MSE A  237  MET  SELENOMETHIONINE
MODRES 4EZI MSE A  281  MET  SELENOMETHIONINE
MODRES 4EZI MSE A  354  MET  SELENOMETHIONINE
MODRES 4EZI MSE A  401  MET  SELENOMETHIONINE
HET    MSE  A  55      13
HET    MSE  A  92       8
HET    MSE  A 138       8
HET    MSE  A 141       8
HET    MSE  A 170       8
HET    MSE  A 204       8
HET    MSE  A 207       8
HET    MSE  A 233       8
HET    MSE  A 237      13
HET    MSE  A 281       8
HET    MSE  A 354      13
HET    MSE  A 401       5
HET    PEG  A 501       7
HET     CL  A 502       1
HETNAM     MSE SELENOMETHIONINE
HETNAM     PEG DI(HYDROXYETHYL)ETHER
HETNAM      CL CHLORIDE ION
FORMUL   1  MSE    12(C5 H11 N O2 SE)
FORMUL   2  PEG    C4 H10 O3
FORMUL   3   CL    CL 1-
FORMUL   4  HOH   *536(H2 O)
HELIX    1   1 SER A   44  LYS A   54  1                                  11
HELIX    2   2 PRO A   57  LEU A   61  5                                   5
HELIX    3   3 VAL A  116  ASN A  120  5                                   5
HELIX    4   4 ASN A  121  LYS A  123  5                                   3
HELIX    5   5 ASN A  124  GLY A  132  1                                   9
HELIX    6   6 GLN A  159  LEU A  181  1                                  23
HELIX    7   7 SER A  195  TYR A  212  1                                  18
HELIX    8   8 GLY A  228  GLU A  239  1                                  12
HELIX    9   9 ARG A  243  SER A  260  1                                  18
HELIX   10  10 GLY A  264  PHE A  269  1                                   6
HELIX   11  11 PRO A  272  MSE A  281  1                                  10
HELIX   12  12 ALA A  286  LEU A  294  1                                   9
HELIX   13  13 ASP A  297  PHE A  302  5                                   6
HELIX   14  14 GLN A  303  SER A  312  1                                  10
HELIX   15  15 ASN A  317  ASN A  326  1                                  10
HELIX   16  16 PRO A  348  LYS A  361  1                                  14
HELIX   17  17 ALA A  380  ARG A  397  1                                  18
SHEET    1   A 7 LEU A  34  PHE A  43  0
SHEET    2   A 7 LEU A  67  GLN A  77 -1  O  ASN A  73   N  VAL A  35
SHEET    3   A 7 LEU A  83  PRO A  93 -1  O  MSE A  92   N  GLN A  68
SHEET    4   A 7 MSE A 138  PRO A 142 -1  O  MSE A 141   N  LEU A  89
SHEET    5   A 7 VAL A 100  GLN A 106  1  N  ILE A 103   O  VAL A 140
SHEET    6   A 7 ILE A 185  TYR A 194  1  O  SER A 186   N  VAL A 100
SHEET    7   A 7 ALA A 219  GLY A 223  1  O  ALA A 221   N  LEU A 191
SHEET    1   B 2 LEU A 336  GLY A 340  0
SHEET    2   B 2 VAL A 366  SER A 370  1  O  TRP A 367   N  LEU A 338
LINK         C   LYS A  54                 N   MSE A  55     1555   1555  1.34
LINK         C   MSE A  55                 N   PRO A  56     1555   1555  1.34
LINK         C   ALA A  91                 N   MSE A  92     1555   1555  1.34
LINK         C   MSE A  92                 N   PRO A  93     1555   1555  1.34
LINK         C   TYR A 137                 N   MSE A 138     1555   1555  1.33
LINK         C   MSE A 138                 N   THR A 139     1555   1555  1.33
LINK         C   VAL A 140                 N   MSE A 141     1555   1555  1.34
LINK         C   MSE A 141                 N   PRO A 142     1555   1555  1.34
LINK         C   ASP A 169                 N   MSE A 170     1555   1555  1.33
LINK         C   MSE A 170                 N   LEU A 171     1555   1555  1.32
LINK         C   VAL A 203                 N   MSE A 204     1555   1555  1.33
LINK         C   MSE A 204                 N   PHE A 205     1555   1555  1.32
LINK         C   GLU A 206                 N   MSE A 207     1555   1555  1.33
LINK         C   MSE A 207                 N   LEU A 208     1555   1555  1.32
LINK         C   THR A 232                 N   MSE A 233     1555   1555  1.33
LINK         C   MSE A 233                 N   HIS A 234     1555   1555  1.32
LINK         C   VAL A 236                 N   MSE A 237     1555   1555  1.34
LINK         C   MSE A 237                 N   LEU A 238     1555   1555  1.34
LINK         C   LEU A 280                 N   MSE A 281     1555   1555  1.34
LINK         C   MSE A 281                 N   ASP A 282     1555   1555  1.33
LINK         C   GLU A 353                 N   MSE A 354     1555   1555  1.33
LINK         C   MSE A 354                 N   ALA A 355     1555   1555  1.34
LINK         C   ALA A 400                 N   MSE A 401     1555   1555  1.34
LINK         C   MSE A 401                 N   ASN A 402     1555   1555  1.33
CISPEP   1 PRO A   56    PRO A   57          0        11.27
CISPEP   2 PRO A  271    PRO A  272          0        -2.42
SITE     1 AC1  4 TYR A 157  GLU A 196  PHE A 251  VAL A 347
SITE     1 AC2  3 GLU A 230  ASN A 326  HOH A 729
CRYST1   50.875   63.488  114.549  90.00  90.00  90.00 P 21 21 21    4
ORIGX1      1.000000  0.000000  0.000000        0.00000
ORIGX2      0.000000  1.000000  0.000000        0.00000
ORIGX3      0.000000  0.000000  1.000000        0.00000
SCALE1      0.019656  0.000000  0.000000        0.00000
SCALE2      0.000000  0.015751  0.000000        0.00000
SCALE3      0.000000  0.000000  0.008730        0.00000
TER    3175      ASN A 402
MASTER      300    0   14   17    9    0    2    6 3506    1  139   29
END